About the PI

Dr. Richard Frock is an Assistant Professor in the Department of Radiation Oncology, Division of Radiation and Cancer Biology at Stanford University.  He received his B.A. in Biochemistry at Vassar College and Ph.D. in Biochemistry from the University of Washington studying A-type nuclear laminopathies in striated muscle and lymphocyte development.  Richard then completed his postdoctoral training at Harvard Medical School and Boston Children’s Hospital where he made seminal contributions to the development (HTGTS) and improvement (LAM-HTGTS) of a high-throughput chromosome translocation sequencing technology, which has been used extensively to locate recurrent and widespread DNA double-stranded breaks (DSBs) genome-wide in developing lymphocytes and cancer cells and to reveal the collateral damage associated with using engineered endonucleases for genome editing. His group is continuing to evolve this technology, most recently described as reJoin and Translocation sequencing (HTGTS-JoinT-seq), to aid in developing novel therapeutics and to further reveal the underlying biological responses to various sources of DNA damage.  

Dr. Frock is a member of the Stanford Cancer Institute (SCI), Maternal and Childhood Health Research Institute (MCHRI), and the Stanford Bio-X Initiative. He is the recipient of the 1st Annual Career Development Award from the Radiation Research Foundation, a V Scholar for the V Foundation for Cancer Research, and is an American Cancer Society Research Scholar.